Document Detail

The emerging role of HDL cholesterol. Is it time to focus more energy on raising high-density lipoprotein levels?
MedLine Citation:
PMID:  11126145     Owner:  NLM     Status:  MEDLINE    
Low HDL cholesterol levels have been found to be a risk factor for CAD. To date, the focus of treating hyperlipidemia has been on lowering LDL cholesterol levels. Now, as more and more compelling data are reported, it is time to begin focusing more energy on how to raise HDL cholesterol levels. If exercise, smoking cessation, and moderate alcohol consumption fail to achieve HDL cholesterol goals, niacin, fibric acid derivatives, or statin drugs may prove helpful in patients at high risk of CAD.
R S Safeer; M O Cornell
Related Documents :
11164415 - Hdl-cholesterol as a marker of coronary heart disease risk: the québec cardiovascular s...
6953075 - Central role of high density lipoprotein in plasma free cholesterol metabolism.
25245085 - Microbial phytase addition resulted in a greater increase in phosphorus digestibility i...
7860745 - Effects of dietary cholesterol and fat saturation on plasma lipoproteins in an ethnical...
8181975 - Circadian fluctuation in heat production of young calves at different ambient temperatu...
14731625 - The np-c gene: a key to pathways of intracellular cholesterol transport.
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Postgraduate medicine     Volume:  108     ISSN:  0032-5481     ISO Abbreviation:  Postgrad Med     Publication Date:  2000 Dec 
Date Detail:
Created Date:  2000-12-27     Completed Date:  2001-01-18     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  0401147     Medline TA:  Postgrad Med     Country:  United States    
Other Details:
Languages:  eng     Pagination:  87-90, 93-8     Citation Subset:  AIM; IM    
Division of Family Practice, George Washington University School of Medicine and Health Sciences, Rockville, MD, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Alcohol Drinking
Antilipemic Agents / therapeutic use
Body Weight
Cholesterol / blood
Cholesterol, HDL / blood,  deficiency*
Coronary Disease / blood,  epidemiology,  etiology*,  prevention & control*
Dietary Fats / administration & dosage,  adverse effects
Estrogen Replacement Therapy
Life Style
Niacin / therapeutic use
Obesity / complications
Physical Fitness
Primary Prevention / methods*
Risk Factors
Smoking / adverse effects
Reg. No./Substance:
0/Antilipemic Agents; 0/Cholesterol, HDL; 0/Dietary Fats; 57-88-5/Cholesterol; 59-67-6/Niacin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Does hypertriglyceridemia increase risk for CAD? Growing evidence suggests it plays a role.
Next Document:  Influential factors affecting prognosis of snakebite patients management: Kaohsiung Chang Gung Memor...